We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-6.61%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$670M
AUM Growth
+$109M
Cap. Flow
+$144M
Cap. Flow %
21.49%
Top 10 Hldgs %
59.4%
Holding
184
New
14
Increased
76
Reduced
55
Closed
39

Top Buys

Rank Stock Value
1
ETP
Energy Transfer Partners, L.P.
ETP
+$71.8M
2
WPZ
Williams Partners L.P.
WPZ
+$17.8M
3
BPL
Buckeye Partners, L.P.
BPL
+$15M
4
EPD icon
Enterprise Products Partners
EPD
+$13.8M
5
ET icon
Energy Transfer Partners
ET
+$13.6M

Top Sells

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$45.5M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$34.1M
3
MPC icon
Marathon Petroleum
MPC
+$6.13M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.81M
5
SSO icon
ProShares Ultra S&P500
SSO
+$4.67M

Sector Composition

Rank Sector Weight
1 Energy 73.91%
2 Healthcare 7.71%
3 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUMO
176
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-2,893
Closed -$627K
KA
177
DELISTED
Kineta, Inc. Common Stock
KA
– –
-191
Closed -$209K
PEGI
178
DELISTED
Pattern Energy Group Inc. Class A
PEGI
– –
-28,286
Closed -$569K
VVC
179
DELISTED
Vectren Corporation
VVC
– –
-2,200
Closed -$129K
SCG
180
DELISTED
Scana
SCG
– –
-13,404
Closed -$876K
CEMP
181
DELISTED
Cempra, Inc.
CEMP
– –
-39,698
Closed -$149K
MACK
182
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
– –
-25,259
Closed -$612K
OMED
183
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
– –
-36,113
Closed -$333K
ETP
184
DELISTED
Energy Transfer Partners L.p.
ETP
– –
-1,244,930
Closed -$45.5M
4 5 6 7
8

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
OC
Optima Capital Beaverton, Oregon $215M AUM 17.28% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Virtus ETF Advisers's Q2 2017 Portfolio in Review

As of Q2 2017, Virtus ETF Advisers held 184 positions worth $670M, up 19% from $562M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Virtus ETF Advisers deployed $144M of net new capital in Q2 2017, opening 14 new positions and adding to 76 existing holdings. Its largest new stake was Jounce Therapeutics, Inc. Common Stock: 18,442 shares worth $259K.

By sector, the portfolio is most concentrated in Energy at 74% of assets, up from 70% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Marathon Petroleum, an estimated $6.13M trimmed.

  • Virtus ETF Advisers's largest Q2 2017 buy was Jounce Therapeutics, Inc. Common Stock: 18,442 shares worth $259K.
  • Virtus ETF Advisers added most to Energy Transfer Partners, L.P. in Q2 2017, an estimated $71.8M increase.
  • Virtus ETF Advisers's biggest Q2 2017 reduction was Marathon Petroleum, cutting an estimated $6.13M.
  • Virtus ETF Advisers fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $45.5M.
  • Virtus ETF Advisers's ten largest holdings make up 59% of its $670M portfolio in Q2 2017.
  • Virtus ETF Advisers opened 14 new positions and closed 39 in Q2 2017.
  • Virtus ETF Advisers's portfolio value rose 19% quarter-over-quarter to $670M.

Based on Virtus ETF Advisers's 13F filing for Q2 2017, filed 14 Aug 2017.